SKP2 mutations occur most frequently in bladder, colorectal, skin and uterine cancers and result in key amino acid substitutions, including L105F (uterine) and S135C (bladder; Figure 4A), that are located within the F-box motif, which is critical for interactions between SKP2 and the SCF complex [44]. Here, KITLG is linked to uterine cancer.